This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Motivational Enhancement for Spanish Speaking Individuals - 1

This study has been completed.
University of Miami
Information provided by:
National Institute on Drug Abuse (NIDA) Identifier:
First received: February 19, 2004
Last updated: January 11, 2017
Last verified: October 2016
The purpose of this study is to compare a three-session Spanish version of Motivational Enhancement Therapy (MET) to standard treatment to see how well MET engages and retains Spanish-speaking clients in outpatient substance abuse treatment.

Condition Intervention Phase
Substance-Related Disorders Behavioral: Behavior Therapy Phase 3

Study Type: Interventional
Study Design: Primary Purpose: Treatment
Official Title: Motivational Enhancement for Spanish Speaking Individuals

Resource links provided by NLM:

Further study details as provided by National Institute on Drug Abuse (NIDA):

Primary Outcome Measures:
  • Treatment retention, drug and alcohol abstinence

Estimated Enrollment: 463
Study Start Date: November 2003
Study Completion Date: October 2005
Primary Completion Date: October 2005 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   18 Years to 99 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

All subjects included unless medical/psychiatrically unstable

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00078169

United States, Colorado
Island Grove RTC
Greeley, Colorado, United States, 80631
United States, Florida
Miami Behavioral Health
Miami, Florida, United States, 33161
United States, New Mexico
Counseling & Psychotherapy Institute
Albuquerque, New Mexico, United States, 87194
The Life Link
Santa Fe, New Mexico, United States, 87505
United States, New York
Narco Freedom (Bridge Plaza)
Long Island City, New York, United States, 11101
United States, Oregon
Changepoint - Cedar Hills Blvd
Portland, Oregon, United States, 97292
Changepoint, Inc.
Portland, Oregon, United States, 97402
Sponsors and Collaborators
Yale University
University of Miami
Principal Investigator: Kathleen Carroll, Ph.D. Yale University
  More Information

Responsible Party: Kathleen Carroll, Ph.D., Yale University School of Medicine Identifier: NCT00078169     History of Changes
Other Study ID Numbers: NIDA-CTN-0021-1
Study First Received: February 19, 2004
Last Updated: January 11, 2017

Keywords provided by National Institute on Drug Abuse (NIDA):
behavioral intervention

Additional relevant MeSH terms:
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders processed this record on August 18, 2017